SpectraCure AB (publ) logo

SpectraCure AB (publ)

SSE:SPEC.ST

Overview | Financials
Company Name SpectraCure AB (publ)
Symbol SPEC.ST
Currency SEK
Price 2.605
Market Cap 253,027,818
Dividend Yield 0%
52-week-range 2.225 - 6.6
Industry Medical Devices
Sector Healthcare
CEO Dr. Masoud Khayyami Ph.D.
Website https://www.spectracure.com

An error occurred while fetching data.

About SpectraCure AB (publ)

SpectraCure AB (publ) focuses on cancer treatment utilizing laser light sources and photo reactive drugs. It develops IDOSE software with interstitial photodynamic therapy system, which is in Phase II clinical trial for the treatment of solid tumors. The company was founded in 2003 and is based in Lund, Sweden.

Related Stocks

Infant Bacterial Therapeutics AB (publ) logo

Infant Bacterial Therapeutics AB (publ)

IBT-B.ST

93.4 SEK

Orexo AB (publ) logo

Orexo AB (publ)

ORX.ST

14.5 SEK

Physitrack PLC logo

Physitrack PLC

PTRK.ST

15.2 SEK

Integrum AB (publ) logo

Integrum AB (publ)

INTEG-B.ST

43.35 SEK

Boule Diagnostics AB (publ) logo

Boule Diagnostics AB (publ)

BOUL.ST

9.36 SEK

Karolinska Development AB (publ) logo

Karolinska Development AB (publ)

KDEV.ST

1.65 SEK

Enzymatica AB (publ) logo

Enzymatica AB (publ)

ENZY.ST

3.05 SEK

Financials

Numbers are in millions USD

Numbers are in millions USD